{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:42:09Z","timestamp":1787892129650,"version":"build-2784847793"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The authors are grateful to acknowledge funding support for this work from the two Cantons of Basel through project grant PMB-02-18 granted by the ETH Zurich."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Myeloid malignancies exhibit considerable heterogeneity with overlapping clinical and genetic features among subtypes. We present a data-driven approach that integrates mutational features and clinical covariates at diagnosis within networks of their probabilistic relationships, enabling the discovery of patient subgroups. A key strength is its ability to include presumed causal directions in the edges linking clinical and mutational features, and account for them aptly in the clustering. In a cohort of 1323 patients, we identify subgroups that outperform established risk classifications in prognostic accuracy. Our approach generalises well to unseen cohorts with classification based on our subgroups similarly offering advantages in predicting prognosis. Our findings suggest that mutational patterns are often shared across myeloid malignancies, with distinct subtypes potentially representing evolutionary stages en route to leukemia. With pancancer TCGA data, we observe that our modelling framework extends naturally to other cancer types while still offering improvements in subgroup discovery.<\/jats:p>","DOI":"10.1038\/s41467-025-59374-1","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T20:15:01Z","timestamp":1745957701000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Network-based clustering unveils interconnected landscapes of genomic and clinical features across myeloid malignancies"],"prefix":"10.1038","volume":"16","author":[{"given":"Fritz","family":"Bayer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Roncador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2739-0454","authenticated-orcid":false,"given":"Giusi","family":"Moffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyomi","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8027-9659","authenticated-orcid":false,"given":"Koichi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0573-6119","authenticated-orcid":false,"given":"Niko","family":"Beerenwinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5357-2705","authenticated-orcid":false,"given":"Jack","family":"Kuipers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"59374_CR1","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1038\/s41375-020-01106-z","volume":"35","author":"G Todisco","year":"2021","unstructured":"Todisco, G. et al. Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2 P95-mutated neoplasms. Leukemia 35, 2371\u20132381 (2021).","journal-title":"Leukemia"},{"key":"59374_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00742-1","volume":"12","author":"A Bidikian","year":"2022","unstructured":"Bidikian, A. et al. Prognostic impact of ASXL1 mutations in chronic phase chronic myeloid leukemia. Blood Cancer J. 12, 144 (2022).","journal-title":"Blood Cancer J."},{"key":"59374_CR3","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1038\/s41375-021-01207-3","volume":"35","author":"O Chan","year":"2021","unstructured":"Chan, O., Renneville, A. & Padron, E. Chronic myelomonocytic leukemia diagnosis and management. Leukemia 35, 1552\u20131562 (2021).","journal-title":"Leukemia"},{"key":"59374_CR4","first-page":"1200","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber, D. A. et al. International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood J. Am. Soc. Hematol. 140, 1200\u20131228 (2022).","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"59374_CR5","first-page":"2292","volume":"100","author":"JW Vardiman","year":"2002","unstructured":"Vardiman, J. W., Harris, N. L. & Brunning, R. D. The world health organization (WHO) classification of the myeloid neoplasms. Blood J. Am. Soc. Hematol. 100, 2292\u20132302 (2002).","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"59374_CR6","first-page":"937","volume":"114","author":"JW Vardiman","year":"2009","unstructured":"Vardiman, J. W. et al. The 2008 revision of the world health organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood J. Am. Soc. Hematol. 114, 937\u2013951 (2009).","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"59374_CR7","first-page":"354","volume":"116","author":"D Grimwade","year":"2010","unstructured":"Grimwade, D. et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood J. Am. Soc. Hematol. 116, 354\u2013365 (2010).","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"59374_CR8","first-page":"2391","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber, D. A. et al. The 2016 revision to the world health organization classification of myeloid neoplasms and acute leukemia. Blood J. Am. Soc. Hematol. 127, 2391\u20132405 (2016).","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"59374_CR9","first-page":"1345","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner, H. et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood J. Am. Soc. Hematol. 140, 1345\u20131377 (2022).","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"59374_CR10","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil, E. et al. Genomic classification and prognosis in acute myeloid leukemia. N. Engl. J. Med. 374, 2209\u20132221 (2016).","journal-title":"N. Engl. J. Med."},{"key":"59374_CR11","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/ng.3756","volume":"49","author":"M Gerstung","year":"2017","unstructured":"Gerstung, M. et al. Precision oncology for acute myeloid leukemia using a knowledge bank approach. Nat. Genet. 49, 332\u2013340 (2017).","journal-title":"Nat. Genet."},{"key":"59374_CR12","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.trecan.2023.05.004","volume":"9","author":"K Takahashi","year":"2023","unstructured":"Takahashi, K. & Tanaka, T. Clonal evolution and hierarchy in myeloid malignancies. Trends Cancer 9, 707\u2013715 (2023).","journal-title":"Trends Cancer"},{"key":"59374_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s43856-023-00298-6","volume":"3","author":"J-N Eckardt","year":"2023","unstructured":"Eckardt, J.-N. et al. Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles. Commun. Med. 3, 68 (2023).","journal-title":"Commun. Med."},{"key":"59374_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38515-4","volume":"14","author":"T Kewan","year":"2023","unstructured":"Kewan, T. et al. Molecular patterns identify distinct subclasses of myeloid neoplasia. Nat. Commun. 14, 3136 (2023).","journal-title":"Nat. Commun."},{"key":"59374_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32103-8","volume":"13","author":"Y Tazi","year":"2022","unstructured":"Tazi, Y. et al. Unified classification and risk-stratification in acute myeloid leukemia. Nat. Commun. 13, 4622 (2022).","journal-title":"Nat. Commun."},{"key":"59374_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41375-022-01779-8","volume":"37","author":"E Jahn","year":"2023","unstructured":"Jahn, E. et al. Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients. Leukemia 37, 1\u201310 (2023).","journal-title":"Leukemia"},{"key":"59374_CR17","doi-asserted-by":"publisher","first-page":"EVIDoa2200008","DOI":"10.1056\/EVIDoa2200008","volume":"1","author":"E Bernard","year":"2022","unstructured":"Bernard, E. et al. Molecular international prognostic scoring system for myelodysplastic syndromes. NEJM Evid. 1, EVIDoa2200008 (2022).","journal-title":"NEJM Evid."},{"key":"59374_CR18","first-page":"9828","volume":"140","author":"S D\u2019Amico","year":"2022","unstructured":"D\u2019Amico, S. et al. Multi-modal analysis and federated learning approach for classification and personalized prognostic assessment in myeloid neoplasms. Blood J. Am. Soc. Hematol. 140, 9828\u20139830 (2022).","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"59374_CR19","first-page":"1408","volume":"128","author":"C Elena","year":"2016","unstructured":"Elena, C. et al. Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia. Blood J. Am. Soc. Hematol. 128, 1408\u20131417 (2016).","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"59374_CR20","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1056\/NEJMoa1716614","volume":"379","author":"J Grinfeld","year":"2018","unstructured":"Grinfeld, J. et al. Classification and personalized prognosis in myeloproliferative neoplasms. N. Engl. J. Med. 379, 1416\u20131430 (2018).","journal-title":"N. Engl. J. Med."},{"key":"59374_CR21","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1200\/JCO.20.01659","volume":"39","author":"M Bersanelli","year":"2021","unstructured":"Bersanelli, M. et al. Classification and personalized prognostic assessment on the basis of clinical and genomic features in myelodysplastic syndromes. J. Clin. Oncol. 39, 1223 (2021).","journal-title":"J. Clin. Oncol."},{"key":"59374_CR22","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/nmeth.2651","volume":"10","author":"M Hofree","year":"2013","unstructured":"Hofree, M., Shen, J. P., Carter, H., Gross, A. & Ideker, T. Network-based stratification of tumor mutations. Nat. Methods 10, 1108\u20131115 (2013).","journal-title":"Nat. Methods"},{"key":"59374_CR23","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1093\/bioinformatics\/btw546","volume":"32","author":"JP Hou","year":"2016","unstructured":"Hou, J. P., Emad, A., Puleo, G. J., Ma, J. & Milenkovic, O. A new correlation clustering method for cancer mutation analysis. Bioinformatics 32, 3717\u20133728 (2016).","journal-title":"Bioinformatics"},{"key":"59374_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06867-x","volume":"9","author":"J Kuipers","year":"2018","unstructured":"Kuipers, J. et al. Mutational interactions define novel cancer subgroups. Nat. Commun. 9, 4353 (2018).","journal-title":"Nat. Commun."},{"key":"59374_CR25","doi-asserted-by":"publisher","first-page":"e1009767","DOI":"10.1371\/journal.pcbi.1009767","volume":"18","author":"P Suter","year":"2022","unstructured":"Suter, P. et al. Multi-omics subtyping of hepatocellular carcinoma patients using a Bayesian network mixture model. PLoS Comput. Biol. 18, e1009767 (2022).","journal-title":"PLoS Comput. Biol."},{"key":"59374_CR26","doi-asserted-by":"publisher","first-page":"24627","DOI":"10.18632\/oncotarget.5685","volume":"6","author":"B Milholland","year":"2015","unstructured":"Milholland, B., Auton, A., Suh, Y. & Vijg, J. Age-related somatic mutations in the cancer genome. Oncotarget 6, 24627\u201324635 (2015).","journal-title":"Oncotarget"},{"key":"59374_CR27","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41568-021-00348-y","volume":"21","author":"S Haupt","year":"2021","unstructured":"Haupt, S., Caramia, F., Klein, S. L., Rubin, J. B. & Haupt, Y. Sex disparities matter in cancer development and therapy. Nat. Rev. Cancer 21, 393\u2013407 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"59374_CR28","doi-asserted-by":"crossref","unstructured":"Moliterno, A. R. & Braunstein, E. M. The roles of sex and genetics in the MPN. In International Review of Cell and Molecular Biology, vol. 366, 1\u201324 (Elsevier, 2022).","DOI":"10.1016\/bs.ircmb.2021.08.001"},{"key":"59374_CR29","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1016\/S2352-3026(22)00323-4","volume":"10","author":"G Maggioni","year":"2023","unstructured":"Maggioni, G. et al. A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study. Lancet Haematol. 10, e117\u2013e128 (2023).","journal-title":"Lancet Haematol."},{"key":"59374_CR30","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/nature07385","volume":"455","author":"TCGA-Research-Network.","year":"2008","unstructured":"TCGA-Research-Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061\u20131068 (2008).","journal-title":"Nature"},{"key":"59374_CR31","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMoa041974","volume":"352","author":"B Falini","year":"2005","unstructured":"Falini, B. et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N. Engl. J. Med. 352, 254\u2013266 (2005).","journal-title":"N. Engl. J. Med."},{"key":"59374_CR32","first-page":"1752","volume":"98","author":"PD Kottaridis","year":"2001","unstructured":"Kottaridis, P. D. et al. The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Blood. J. Am. Soc. Hematol. 98, 1752\u20131759 (2001).","journal-title":"Blood. J. Am. Soc. Hematol."},{"key":"59374_CR33","first-page":"2776","volume":"111","author":"RE Gale","year":"2008","unstructured":"Gale, R. E. et al. The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia. Blood, J. Am. Soc. Hematol. 111, 2776\u20132784 (2008).","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"59374_CR34","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1182\/bloodadvances.2021006239","volume":"6","author":"OK Weinberg","year":"2022","unstructured":"Weinberg, O. K. et al. TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS\/AML. Blood Adv. 6, 2847\u20132853 (2022).","journal-title":"Blood Adv."},{"key":"59374_CR35","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.1200\/JCO.2006.06.9500","volume":"24","author":"P Paschka","year":"2006","unstructured":"Paschka, P. et al. Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv (16) and t (8; 21): a cancer and leukemia group B study. J. Clin. Oncol. 24, 3904\u20133911 (2006).","journal-title":"J. Clin. Oncol."},{"key":"59374_CR36","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1002\/cam4.2947","volume":"9","author":"C Prats-Mart\u00edn","year":"2020","unstructured":"Prats-Mart\u00edn, C. et al. ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia-related changes and normal karyotype. Cancer Med. 9, 3637\u20133646 (2020).","journal-title":"Cancer Med."},{"key":"59374_CR37","first-page":"3651","volume":"11","author":"P Wu","year":"2019","unstructured":"Wu, P. et al. Co-occurrence of RUNX1 and ASXL1 mutations underlie poor response and outcome for MDS patients treated with HMAs. Am. J. Transl. Res. 11, 3651 (2019).","journal-title":"Am. J. Transl. Res."},{"key":"59374_CR38","first-page":"3005","volume":"121","author":"E Such","year":"2013","unstructured":"Such, E. et al. Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia. Blood. J. Am. Soc. Hematol. 121, 3005\u20133015 (2013).","journal-title":"Blood. J. Am. Soc. Hematol."},{"key":"59374_CR39","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.3324\/haematol.2014.115113","volume":"100","author":"S Shirane","year":"2015","unstructured":"Shirane, S. et al. JAK2, CALR, and MPL mutation spectrum in Japanese patients with myeloproliferative neoplasms. Haematologica 100, e46 (2015).","journal-title":"Haematologica"},{"key":"59374_CR40","doi-asserted-by":"publisher","first-page":"E5401","DOI":"10.1073\/pnas.1407792111","volume":"111","author":"R Rampal","year":"2014","unstructured":"Rampal, R. et al. Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms. Proc. Natl Acad. Sci. 111, E5401\u2013E5410 (2014).","journal-title":"Proc. Natl Acad. Sci."},{"key":"59374_CR41","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1002\/ajh.24901","volume":"92","author":"A Tefferi","year":"2017","unstructured":"Tefferi, A. et al. Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R. Am. J. Hematol. 92, 1311\u20131317 (2017).","journal-title":"Am. J. Hematol."},{"key":"59374_CR42","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/cncr.34535","volume":"129","author":"RM Shallis","year":"2023","unstructured":"Shallis, R. M. et al. TP53-altered acute myeloid leukemia and myelodysplastic syndrome with excess blasts should be approached as a single entity. Cancer 129, 175\u2013180 (2023).","journal-title":"Cancer"},{"key":"59374_CR43","doi-asserted-by":"publisher","first-page":"204062072095500","DOI":"10.1177\/2040620720955006","volume":"11","author":"JP Bewersdorf","year":"2020","unstructured":"Bewersdorf, J. P., Carraway, H. & Prebet, T. Emerging treatment options for patients with high-risk myelodysplastic syndrome. Therap. Adv. Hematol. 11, 2040620720955006 (2020).","journal-title":"Therap. Adv. Hematol."},{"key":"59374_CR44","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1038\/s41375-021-01218-0","volume":"35","author":"J Stomper","year":"2021","unstructured":"Stomper, J., Rotondo, J. C., Greve, G. & L\u00fcbbert, M. Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based therapies. Leukemia 35, 1873\u20131889 (2021).","journal-title":"Leukemia"},{"key":"59374_CR45","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/s41591-022-01819-x","volume":"28","author":"AG Zeng","year":"2022","unstructured":"Zeng, A. G. et al. A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia. Nat. Med. 28, 1212\u20131223 (2022).","journal-title":"Nat. Med."},{"key":"59374_CR46","unstructured":"Zeng, A. G. et al. Precise single-cell transcriptomic mapping of normal and leukemic cell states reveals unconventional lineage priming in acute myeloid leukemia. bioRxiv:2023.12.26.573390 (2023)."},{"key":"59374_CR47","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1038\/s41375-024-02211-z","volume":"38","author":"M Schwede","year":"2024","unstructured":"Schwede, M. et al. Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity. Leukemia 38, 1501\u20131510 (2024).","journal-title":"Leukemia"},{"key":"59374_CR48","unstructured":"Rios, F. L., Moffa, G. & Kuipers, J. Exact discovery is polynomial for sparse causal Bayesian networks. arXiv:2406.15012 (2024)."},{"key":"59374_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren, W. et al. The Ensembl variant effect predictor. Genome Biol. 17, 1\u201314 (2016).","journal-title":"Genome Biol."},{"key":"59374_CR50","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1101\/gr.176601","volume":"11","author":"PC Ng","year":"2001","unstructured":"Ng, P. C. & Henikoff, S. Predicting deleterious amino acid substitutions. Genome Res. 11, 863\u2013874 (2001).","journal-title":"Genome Res."},{"key":"59374_CR51","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei, I. A. et al. A method and server for predicting damaging missense mutations. Nat. Methods 7, 248\u2013249 (2010).","journal-title":"Nat. Methods"},{"key":"59374_CR52","doi-asserted-by":"publisher","first-page":"i160","DOI":"10.1093\/bioinformatics\/btae209","volume":"40","author":"P Wall","year":"2024","unstructured":"Wall, P. & Ideker, T. Representing mutations for predicting cancer drug response. Bioinformatics 40, i160\u2013i168 (2024).","journal-title":"Bioinformatics"},{"key":"59374_CR53","first-page":"1753","volume":"140","author":"AS Sperling","year":"2022","unstructured":"Sperling, A. S. et al. Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms. Blood. J. Am. Soc. Hematol. 140, 1753\u20131763 (2022).","journal-title":"Blood. J. Am. Soc. Hematol."},{"key":"59374_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/1752-0509-3-54","volume":"3","author":"Y Ko","year":"2009","unstructured":"Ko, Y., Zhai, C. & Rodriguez-Zas, S. Inference of gene pathways using mixture Bayesian networks. BMC Syst. Biol. 3, 54 (2009).","journal-title":"BMC Syst. Biol."},{"key":"59374_CR55","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/0004-3702(90)90060-D","volume":"42","author":"GF Cooper","year":"1990","unstructured":"Cooper, G. F. The computational complexity of probabilistic inference using Bayesian belief networks. Artif. Intell. 42, 393\u2013405 (1990).","journal-title":"Artif. Intell."},{"key":"59374_CR56","unstructured":"Bayer, F. M., Moffa, G., Beerenwinkel, N. & Kuipers, J. High-dimensional inference in Bayesian networks. arXiv:2112.09217 (2022)."},{"key":"59374_CR57","doi-asserted-by":"crossref","unstructured":"Maathuis, M., Drton, M., Lauritzen, S. & Wainwright, M. Handbook of Graphical Models (CRC Press, 2018).","DOI":"10.1201\/9780429463976"},{"key":"59374_CR58","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1080\/10618600.2021.2020127","volume":"31","author":"J Kuipers","year":"2022","unstructured":"Kuipers, J., Suter, P. & Moffa, G. Efficient sampling and structure learning of Bayesian networks. J. Comput. Graph. Stat. 31, 639\u2013650 (2022).","journal-title":"J. Comput. Graph. Stat."},{"key":"59374_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v105.i09","volume":"105","author":"P Suter","year":"2023","unstructured":"Suter, P., Kuipers, J., Moffa, G. & Beerenwinkel, N. Bayesian structure learning and sampling of Bayesian networks with the R package BiDAG. J. Stat. Softw. 105, 1\u201331 (2023).","journal-title":"J. Stat. Softw."},{"key":"59374_CR60","doi-asserted-by":"publisher","first-page":"D447","DOI":"10.1093\/nar\/gku1003","volume":"43","author":"D Szklarczyk","year":"2015","unstructured":"Szklarczyk, D. et al. STRING v10: protein\u2013protein interaction networks, integrated over the tree of life. Nucleic acids Res. 43, D447\u2013D452 (2015).","journal-title":"Nucleic acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59374-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59374-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59374-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T04:34:08Z","timestamp":1746506048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59374-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["59374"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-59374-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.10.25.563992","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"3 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4043"}}